Search

Sanjeev G Redkar

from San Ramon, CA
Get Report
Also known as:
Sanjeev Gurunath Redkar
Phone and address:
2208 Rosemount Ln, San Ramon, CA 94582
(925) 560-8123
Related to:
Hema RedkarGurunath RedkarMonisha S Redkar, 53
Connected to:
Rajendra J Redkar, 69Rohan Redkar, 39John C Redkettle, 32Charles H Redkey, 95Curtis M Redkey, 56Olena Redkina, 42Olga Redkina, 42Anna V Redko, 36Garhart E Redl, 43Sarah A Redl, 39

Sanjeev Redkar Phones & Addresses

  • 2208 Rosemount Ln, San Ramon, CA 94582 (925) 560-8123
  • 2740 Breaker Cir, Hayward, CA 94545

Work

Company: Supergen Jun 1998 to Oct 2011 Position: Vp, manufacturing and preclinical development

Industries

Pharmaceuticals

Resumes

Resumes

Sanjeev Redkar Photo 1

Vp, Pharmaceutical Development And Manufacturing At Astex Pharmaceuticals Inc.

View page
Location:
San Francisco Bay Area
Industry:
Pharmaceuticals
Work:
SuperGen Jun 1998 - Oct 2011
VP, Manufacturing and Preclinical Development
SuperGen Sep 2001 - Oct 2003
Senior Director, Pharmaceutical Operations
SuperGen Jun 1998 - Sep 2001
Senior Manager, Manufacturing and Process Development
Matrix Pharmaceutical 1994 - 1998
Research Scientist

Publications

Us Patents

Compositions And Formulations Of 9-Nitrocamptothecin Polymorphs And Methods Of Use Therefor

View page
US Patent:
6492379, Dec 10, 2002
Filed:
Feb 21, 2002
Appl. No.:
10/081998
Inventors:
Sanjeev Redkar - Union City CA
Ashok Gore - San Ramon CA
Assignee:
Super Gen, Inc. - Dublin CA
International Classification:
A61K 314738
US Classification:
514283, 546 48
Abstract:
A polymorphic form of 9-nitrocamptothecin is provided, the polymorph being characterizable as having, by differential scanning calorimetry, an endotherm at between 175. 5 and 177. 5Â C. , an exotherm at between 181. 7 and 183. 7Â C. , and an IR spectrum with no absorption centered between 3625 cm and 3675 cm.

Compositions And Formulations Of 9-Nitrocamptothecin Polymorphs And Methods Of Use Thereof

View page
US Patent:
6696458, Feb 24, 2004
Filed:
Oct 8, 2002
Appl. No.:
10/267909
Inventors:
Sanjeev Redkar - Union City CA
Ashok Gore - San Ramon CA
Assignee:
Super Gen, Inc. - Dublin CA
International Classification:
A61K 314738
US Classification:
514283, 546 48
Abstract:
Amorphous forms of 9-nitrocamptothecin are provided by grinding or pulverizing different polymorphic forms of 9-nitrocamptothecin, and the polymorphic forms are characterizable as having an X-ray powder diffraction pattern with discernable diffraction lines at different Â2 values for Cu K radiation having a wavelength of 1. 5406 Angstrom.

Method For Preparing And Using Polyoxyethylated Castor Oil In Pharmaceutical Compositions

View page
US Patent:
6710195, Mar 23, 2004
Filed:
Nov 26, 2002
Appl. No.:
10/306824
Inventors:
Rajashree Joshi-Hangal - Union City CA
Joseph Rubinfeld - Danville CA
Sanjeev Redkar - Union City CA
Ashok Y. Gore - San Ramon CA
Assignee:
SuperGen, Inc. - Dublin CA
International Classification:
C07C 5116
US Classification:
554132, 514449
Abstract:
A method is provided for preparing a pharmaceutical composition comprising: taking polyoxyethylated castor oil which if diluted 1:10 in water has a pH greater than 5 and aging the polyoxyethylated castor oil by exposing the polyoxyethylated castor oil to a gas comprising oxygen for a period of time, the exposure to the gas over the period of time causing an acidity of the polyoxyethylated castor oil to increase; and forming a pharmaceutical composition comprising the aged polyoxyethylated castor oil and a pharmaceutically active agent such as paclitaxel; wherein at least 80% of the potency of the pharmaceutically active agent is retained by the pharmaceutical composition after the pharmaceutical composition is stored for at least 7 days at 40Â C.

Compositions And Formulations Of 9-Nitrocamptothecin Polymorphs And Methods Of Use Thereof

View page
US Patent:
6756381, Jun 29, 2004
Filed:
Feb 21, 2002
Appl. No.:
10/081991
Inventors:
Sanjeev Redkar - Union City CA
Ashok Gore - San Ramon CA
Assignee:
SuperGen, Inc. - Dublin CA
International Classification:
A61K 3144
US Classification:
514283, 546 51
Abstract:
A polymorphic form of 9-nitrocamptothecin is provided, the polymorph being characterizable as having an IR spectrum with an absorption centered between 3625 cm and 3675 cm and containing more than a trace of water.

Liquid Formulation Of Decitabine And Use Of The Same

View page
US Patent:
6982253, Jan 3, 2006
Filed:
Jun 5, 2002
Appl. No.:
10/164276
Inventors:
Rajashree Joshi-Hangal - Union City CA, US
Xichen Zhang - Thousand Oaks CA, US
Stephanie Gong - Pleasanton CA, US
Sanjeev Redkar - Union City CA, US
Ashok Y. Gore - San Ramon CA, US
Assignee:
SuperGen, Inc. - Dublin CA
International Classification:
A01N 43/04
A61K 31/70
US Classification:
514 49, 514 42, 514 43
Abstract:
Pharmaceutical formulations, kits and vessels are provided for delivering decitabine to a patient suffering from a disease in need of treatment with decitabine. The pharmaceutical formulation comprises decitabine solvated in a non-aqueous solvent that comprises glycerin, propylene glycol, polyethylene glycol, or combinations. Such formulations are more chemically stable than conventional liquid formulations of decitabine containing more than 40% water in volume. The pharmaceutical formulations can be used for any disease that is sensitive to the treatment with decitabine, such as hematological disorders and cancer.

Compositions And Formulations Of 9-Nitrocamptothecin Polymorphs And Methods Of Use Therefor

View page
US Patent:
7049322, May 23, 2006
Filed:
Feb 21, 2002
Appl. No.:
10/082003
Inventors:
Sanjeev Redkar - Union City CA, US
Ashok Gore - San Ramon CA, US
Assignee:
SuperGen, Inc. - Dublin CA
International Classification:
A61K 31/44
US Classification:
514283, 514279, 424464
Abstract:
A polymorphic form of 9-nitrocamptothecin is provided, the polymorph being characterizable as having, by differential scanning calorimetry, an endotherm at between 273. 9 to 275. 9 C. , and an exotherm at between 279. 3 and 281. 3 C.

Compositions And Formulations Of 9-Nitrocamptothecin Polymorphs And Methods Of Use Therefor

View page
US Patent:
7071202, Jul 4, 2006
Filed:
Feb 21, 2002
Appl. No.:
10/080530
Inventors:
Sanjeev Redkar - Union City CA, US
Ashok Gore - San Ramon CA, US
Assignee:
SuperGen, Inc. - Dublin CA
International Classification:
A61K 31/44
US Classification:
514283, 514279, 424464
Abstract:
A polymorphic form of 9-nitrocamptothecin is provided, the polymorph being characterizable as having, by differential scanning calorimetry, no observable endotherm and an exotherm at between 273. 6 and 275. 6 C. , and a solution NMR spectrum with multiplets at 1. 7 and 3. 7 ppm shifts.

Method Of Administering Decitabine

View page
US Patent:
7135464, Nov 14, 2006
Filed:
Jul 13, 2004
Appl. No.:
10/890755
Inventors:
Rajashree Joshi-Hangal - Union City CA, US
Xichen Zhang - Thousand Oaks CA, US
Stephanie Gong - Pleasanton CA, US
Sanjeev Redkar - Union City CA, US
Ashok Y. Gore - San Ramon CA, US
Assignee:
SuperGen, Inc. - Dublin CA
International Classification:
A01N 43/04
A61K 31/70
A61K 9/00
US Classification:
514 49, 514 42, 514 43
Abstract:
Pharmaceutical formulations, kits and vessels are provided for delivering decitabine to a patient suffering from a disease in need of treatment with decitabine. The pharmaceutical formulation comprises decitabine solvated in a non-aqueous solvent that comprises glycerin, propylene glycol, polyethylene glycol, or combinations. Such formulations are more chemically stable than conventional liquid formulations of decitabine containing more than 40% water in volume. The pharmaceutical formulations can be used for any disease that is sensitive to the treatment with decitabine, such as hematological disorders and cancer.
Control profile
Sanjeev G Redkar from San Ramon, CA Get Report